Lesage Anne's Form 4 filing
Pharvaris N.V. (PHVS) · filed Apr 24, 2026
- Accession no.
- 0001193125-26-176222
- Filed
- Apr 24, 2026
- Trade date
- Apr 22-23, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $441.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lesage AnneCIK 0001973705 | Officer (Chief Early Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | Common Stock | MOption exerciseAcquired | +500 | $2.59 | +$1,295 | 56,950 | Direct | |
| Apr 22, 2026 | Common Stock | SSaleDisposed | −500 | $30.00 | −$15,000 | 56,450 | Direct | |
| Apr 22, 2026 | Common Stock | MOption exerciseAcquired | +7,000 | $8.05 | +$56,350 | 63,450 | Direct | |
| Apr 22, 2026 | Common Stock | SSaleDisposed | −7,000 | $30.05F2 | −$210,350 | 56,450 | Direct | |
| Apr 22, 2026 | Common Stock | SSaleDisposed | −7,000 | $30.05F2 | −$210,350 | 156,969 | Indirect | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −100 | $30.03 | −$3,003 | 156,869 | Indirect | |
| Apr 23, 2026 | Common Stock | MOption exerciseAcquired | +100 | $2.59 | +$259 | 56,550 | Direct | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −100 | $30.03F3 | −$3,003 | 56,450 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | Common Stock | MOption exerciseDisposed | −500 | $0.00 | $0 | 15,972 | Direct | |
| Apr 22, 2026 | Common Stock | MOption exerciseDisposed | −7,000 | $0.00 | $0 | 113,000 | Direct | |
| Apr 23, 2026 | Common Stock | MOption exerciseDisposed | −100 | $0.00 | $0 | 15,872 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13.
Referenced by the price of 2 transactions in Table I.
- F3
These shares were sold in multiple transactions at prices ranging from $30.03 to $31.03.
Referenced by the price of 1 transaction in Table I.